IHeartBadCode , 11 months ago

Just FYI for semantics. Generics is a term usually for small molecular weight compounds, usually under 900 daltons. Biosimilars is the term for higher molecular weight.

Doing generics is a lot simpler than biosimilars, in both you must wait for the patient to run out. But biosimilars are less likely to be made using an alternative process than the original trade secret process. This is due in part to the higher molecular weight which means a more complex compound.